Myoview Injection, Powder, Lyophilized, For Solution
Product Images NDC 17156-024

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Myoview (NDC 17156-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medi-physics Inc. Dba Ge Healthcare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Myoview 01)

Image (Myoview 01)
This appears to be a set of instructions or guidelines for conducting a chemical analysis, likely using chromatography. It includes measurements in centimeters, references to an origin point, and instructions for counting radioactivity in different sections and calculating radiochemical purity as a percentage based on those counts.*
FDA Label Image

Chemical Structure (Myoview 02)

FDA Label Image

Principal Display Panel (5 Vial Kit Label)

Principal Display Panel (5 Vial Kit Label)
This is a description of a kit called MYOVIEWâ„¢ by GE Healthcare. It is a sterile kit containing 5 vials for the preparation of a technetium Tc99m olagnostic tetrofosmin injection for diagnostic purposes. The recommended dosage is provided in the prescribing information. The kit should be stored in the refrigerator and the reconstituted injection should be stored using appropriate radiation shielding. The kit contains no antimicrobial preservative and is not suitable for use in humans unless technetium Tc99m is added. The kit is manufactured for GE Healthcare by GE Healthcare AS, Oslo, Norway. It also contains pressure-sensitive labels and prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.